Loss of Ambra1 promotes melanoma growth and invasion

Luca Di Leo1, Valérie Bodemeyer1, Francesca M Bosisio2

  • 1Melanoma Research Team, Cell Stress and Survival Unit, Center for Autophagy, Recycling and Disease (CARD), Danish Cancer Society Research Center, Copenhagen, Denmark.

Insights

Activating Molecule in Beclin-1-Regulated Autophagy (Ambra1) acts as a tumor suppressor in melanoma. Its deficiency accelerates tumor growth and metastasis, suggesting FAK1 inhibition as a therapeutic strategy for Ambra1-low melanoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Melanoma remains a deadly skin cancer with unmet therapeutic needs.
  • Understanding melanoma's molecular drivers is crucial for developing new treatments.

Purpose of the Study:

  • To investigate the role of Activating Molecule in Beclin-1-Regulated Autophagy (Ambra1) in melanoma development.
  • To explore potential therapeutic strategies targeting Ambra1 in melanoma.

Main Methods:

  • Utilized Braf/Pten-mutated mouse models of melanoma.
  • Assessed tumor growth, survival rates, cell motility, invasion, and epithelial-mesenchymal transition (EMT)-like processes.
  • Analyzed extracellular matrix remodeling and focal adhesion kinase 1 (FAK1) signaling pathways.

Main Results:

  • Ambra1 deficiency accelerated tumor growth and decreased survival in mouse models.
  • Ambra1 deletion promoted melanoma aggressiveness, increasing cell motility, invasion, and EMT.
  • Ambra1 deficiency led to altered extracellular matrix and hyperactivated FAK1 signaling.

Conclusions:

  • Ambra1 functions as a tumor suppressor in melanoma.
  • FAK1 signaling inhibition can reduce melanoma invasion and growth.
  • Targeting FAK1 is a potential therapeutic strategy for melanoma with low Ambra1 expression.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.3K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K